Cytokines in streptococcal infections - An opening lecture

Advances in Experimental Medicine and Biology

Volumn 418, Issue , 1997, Pages 869-879

  Cavaillon, Jean Marc ^a   Müller Alouf, Heide ^b   Alouf, Joseph E ^b  

^a INSTITUT PASTEUR   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MONONUCLEAR CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INDUCTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANIMALS; CELL MEMBRANE; CYTOKINES; HUMANS; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; SUPERANTIGENS;

EID: 0030778999     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1825-3_206     Document Type: Article

References (24)

1. Abe J, Forrester J, Nakahara T, Lafferty JA, Kotzin BL, Leung DYM. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol 1991; 146:3747-50.
2. Alouf JE, Geoffroy C. The family of antigenically-related cholesterol-binding ("sulfhydryl-activated") cytolytic toxins. In Sourcebook of Bacterial Toxins (Alouf JE, and Freer JN Eds) London: Academic Press, 1991.
3. Bayston K, Tomlinson M, Cohen J. In-vitro stimulation of TNF-alpha from human whole blood by cell-free supernatants of gram-positive bacteria. Cytokine 1992;4:397-402.
4. Benabdelmoumene S, Dumont S, Petit C, Poindron P, Wachsmann D, Klein JP. Activation of human monocytes by Streptococcus mutans serotype f polysaccharide: immunoglobulin G Fc receptor expression and tumor necrosis factor and interleukin-1 production. Infect Immun 1991;59:3261-6.
5. Benton KA, Everson MP, Briles DE. A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect Immun 1995;63:448-55.
6. Beutler B, Milsark IW, Cerami AC. Passive immunization against cahectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869-71.
7. Braun MA, Gerlach D, Hartwig UF, et al. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins). J Immunol 1993; 150:2457-66.
8. Cavaillon JM. Controversies surrounding current therapies for sepsis syndrome. Bull Inst Pasteur 1995:93:21-41.
9. Cavaillon JM, Alouf JE. Mitogenicity of streptococcal extracellular products and antagonism with concanavalin A. Immunol Lett 1982;5:317-22.
10. Cavaillon JM, Geoffroy C, Alouf JE. Purification of two extracellular streptococcal mitogens and their effects on human, rabbit, and mouse lymphocytes. J Clin Lab Immunol 1979;2:155-63.
11. Cavaillon JM, Leclerc C, Alouf JE. Polyclonal antibody-forming cell activation and immunomodulation of the invitro immune response induced by streptococcal extracellular products. Cell Immunol 1983;76:200-6.
12. Cavaillon JM, Munoz C, Fitting C, Misset B, Carlet J. Circulating cytokines: the tip of the iceberg? Circ Shock 1992:38:145-52.
13. Cavaillon JM, Rivière Y, Svab J, Montagnier L, Alouf JE. Induction of interferon by streptococcus pyogenes extracellular products. Immunol Lett 1982;5:323-26.
14. Cleveland M, Gorham J, Murphy T, Tuomanen E. KM M. Lipoteichoic acid preparations of Gram positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996:64:1906-1912.
15. Cusumano V, Genovese F. Mancuso G, Carbone M, Fera MT, Teti G. Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect Immun 1996;64:2850-52.
16. Fast DJ, Schlievert PM, Nelson RD. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun 1989:57:291-4.
17. Follows GA, Munk ME, Gatrill AJ, Conradt P, Kaufmann SH. Gamma interferon and interleukin 2, but not interleukin 4, are detectable in gamma/delta T-cell cultures after activation with bacteria. Infect Immun 1992:60:1229-31.
18. Geoffroy C, Müller-Alouf H, Champagne E, Cavaillon J-M, Alouf JE. Identification of a new extracellular mitogen from group A streptococci. Zbl Bakteriol 1994;suppl.24:90-91.
19. Gerlach D, Knoll H, Kohler W, Ozegowski JH, Hribalova V. Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zentralbl Bakteriol Mikrobiol Hyg [a] 1983;255:221-33.
20. Gerlach DH, Alouf JE, 'Moravek L, Pavlik M, Köhler W. The characterization of two new low molecular weight proteins (LMPs) from Streptococcus pyogenes. Zbl Bakteriol 1992:277:1-9.
21. Gonzalo J, Gonzales-Garcia A, Kalland T, Hedlund G, Martinez A, G K. Linomide, a novel immunomodulator that prevents death in four models of septic shock. Eur J Immunol 1993:23:2372-74.
22. Hackett SP, Stevens DL. Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis 1992:165:879-85.
23. Hackett SP, Stevens DL. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis. J Infect Dis 1993:168:232-5.
24. Helfgott DC, Tatter SB, Santhanam U, et al. Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 1989; 142:948-53.